| Stephen Stills Cancer Surgery A Success
Nash was a guest on the show to pay tribute to the late Dan Fogelberg, who had died of prostate cancer that week, when he let slip that Stills was also diagnosed with the cancer. Nash told King in a matter of fact manner "Unlike Danny, who left it too long to be seriously checked, Stephen found his at an early stage." Stills wife Kristen says all went well with the operation. "Stephen's procedure went remarkably well and he couldn't be better. He will be home by noon tomorrow and the pain will be minimal," she said. Stephen is planning to attend the Sundance Film Festival in Utah on January 25th for the world premiere of the move 'CSNY/Déjà Vu' which documented the 2006 Crosby, Still, Nash & Young Freedom of Speech tour. .
Selig: Giants should have reported Bonds' trainer
The operation was done at Denver Health Medical Center. Kim said a "right testicular mass was found incidentally and it was managed surgically." The tumor was found last week in an exam by team physician Dr. Saurabh Mangalik . "I want to thank my fans, my teammates, the Nuggets organization and everyone that's been supporting me," Nene said in a statement released by the team before Tuesday night's game at Atlanta. "My victory will represent their victory as well. Thanks for being with me in this moment. I will remember all the appreciation. I thank God that we could detect this at such an early stage." Denver coach George Karl noted that he and his son, Coby, have fought cancer. George Karl has had surgery for prostate cancer. "As a cancer survivor and someone who has watched his son go through two cancer-related surgeries, I know firsthand the emotions and fears that you feel when someone says you might have it," Karl said.
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM ...
PRINCETON, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Pharmacopeia (NASDAQ: PCOP) , an innovator in the discovery and development of novel small molecule therapeutics, today announced that it has licensed from Bristol-Myers Squibb (NYSE: BMY) a selective androgen receptor modulator (SARM) program, including a lead compound in Phase 1 clinical development and back-up compounds. PS178990 is a non-steroidal selective androgen receptor modulator, or SARM, which was designed to provide the benefits of testosterone without its unwanted side effects on prostate. The program has completed a Phase 1 single ascending dose study. SARM agonists are a potential novel treatment for muscle wasting associated with a number of serious chronic and acute medical conditions such as surgical and severe burn recovery, end-stage renal disease and cancer- and AIDS-related cachexia.
|
